Denver, CO, August 15, 2007 --(PR.com
)-- The “Overview of USP 797” technical paper, authored by Baxa Corporation’s Mike Hurst, RPh, MBA, is now available at http://expert411.com/_wsn/page3.html for media and professional access. Most hospital pharmacists simply want to comply with the basic requirements of USP 797 and get on with the business of patient care. This paper is intended to help pharmacies get started in that direction. It also discusses USP 797 from several unique angles not necessarily considered in the initial literature published on the subject.
This technical paper and links to eight other related publications are now available along with Hurst’s Expert Profile information at the Expert411.com site. Other topics include:
* Oral Medication Dispensers in Clinical Research
* Enteral Feeding Misconnections
* Environmental Controls for Sterile Compounding
* The Limitations of Isolators
* Pharmacy Considerations for Syringe Batch Processing
* Safe Handling of Hazardous Drugs
* USP 797 Requirements for Automated Compounders
* Risk Level Assessment of Compounded Sterile Preparations
Hurst worked for 18 years at Swedish Medical Center in Seattle, Washington in operational management, including positions as IV Supervisor and Assistant Director of Pharmacy. His implementation of a syringe infusion system in 1984 had national implications. For the next nine years Hurst wrote, spoke, consulted and acted as a reference site for syringe infusion installations across the country.
Moving to industry full time in 1994, Hurst joined Baxa Corporation as Vice President of Infusion Systems. His job duties have included customer support for syringe infusion system installations, new business and product development roles, and professional services support for various Baxa pharmacy and nursing product lines. Hurst is currently consulting with a hospital system in the development of a comprehensive USP 797 compliance template that can be applied in other hospital pharmacies.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR, Absolutely Public Relations